|

Ipilumimab Clinical Trials

1 actively recruiting trial

Also known as: Immunotherapy

Pipeline

Phase 2: 1

Top Sponsors

  • The Netherlands Cancer Institute1

Indications

  • Cutaneous Squamous Cell Carcinoma of the Head and Neck1
  • Cutaneous Squamous Cell Carcinoma (CSCC)1
  • Cutaneous Squamous Cell Cancer1
  • Cutaneous Squamous Cell Carcinoma1
  • Cancer1

Other1 trial

Towards Cure Via Only Ultra-short ICB in CSCC
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.